featured
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Nitrosamines: A new systematic review |
|
11 | 2104 | April 14, 2024 |
| Risk Assessment Study of Nitrosamines for the API Temozolomide Industrial Process -Pub |
|
1 | 626 | February 6, 2024 |
| 🇪🇺 EDQM - top 10 deficiencies observed in new CEP applications |
|
0 | 437 | March 14, 2024 |
| 🇪🇺 OMCL Network published NDSRIs Analytical Methods |
|
1 | 611 | March 11, 2024 |
| Nitrosamines evaluation in transdermal patches |
|
10 | 1292 | March 5, 2024 |
| CDER Drug Safety Priorities Fiscal Year 2023 |
|
1 | 313 | February 16, 2024 |
| Visualization of Categorized Compounds by CPCA |
|
56 | 5807 | February 5, 2024 |
| 🇪🇺 EMA/409815/2020 Rev.20 |
|
7 | 1974 | January 31, 2024 |
| Modeling the Impact of Excipients Selection on Nitrosamine Formation towards Risk Mitigation |
|
11 | 1702 | December 5, 2023 |
| Nitrosamines: Mass Spectrometry-Based Analytical Procedures |
|
3 | 1749 | August 29, 2023 |
| The Nitrosamine “Saga” |
|
3 | 1425 | July 29, 2023 |